BOEHRINGER MANNHEIM LAUNCHES ACCU-CHEK ADVANTAGE BLOOD GLUCOSE MONITOR
This article was originally published in The Tan Sheet
Executive Summary
BOEHRINGER MANNHEIM LAUNCHES ACCU-CHEK ADVANTAGE BLOOD GLUCOSE MONITOR at the American Diabetes Association convention in New Orleans June 11-14. The most recent addition to Boehringer's Accu- Chek line, Advantage began shipping to retail outlets in May and is currently sold at prices ranging from $50 to $75, excluding rebates.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning